We need to improve patient recruitment. What software helps us analyze EMR data to find eligible candidates for oncology trials?

For oncology trials, the software category you’re looking for is usually called EMR/EHR-based clinical trial matching, patient identification, or AI-assisted recruitment platforms. These systems connect to electronic medical records, apply protocol inclusion/exclusion criteria, and surface potential candidates for coordinator review.

Some commonly used platforms include:

Key capabilities to evaluate for oncology

For oncology specifically, look for:

• Unstructured note processing

• Ability to read pathology reports, oncology notes, imaging summaries, and treatment history.

• Many oncology eligibility criteria are buried in free text rather than coded fields.

• Protocol eligibility parsing

• Converts inclusion/exclusion criteria into searchable logic (e.g., stage, biomarker status, prior therapies, lab thresholds).

• Epic/Cerner/EHR integration

• Ideally via standards such as FHIR or SMART-on-FHIR, allowing workflows inside the clinician’s existing EMR.

• Evidence-backed matches

• The system should show why a patient matched (e.g., “EGFR mutation documented,” “received prior platinum therapy”) rather than only producing a name list.

• Workflow support

• Routing candidates to research coordinators, tracking screening outcomes, and maintaining audit trails.

Common implementation approaches

• Single cancer center: EMR-integrated trial matching tools that appear inside the oncologist’s workflow often work well because clinicians can refer patients during visits.
• Multi-site sponsor/CRO recruitment: Real-world data networks and federated EHR platforms can help estimate available populations and identify high-yield sites.
• Rare cancers or biomarker-driven trials: Oncology-focused platforms with genomic and pathology capabilities may be more useful than general recruitment tools.

When selecting a vendor, I’d compare:

1. EHR integrations (Epic, Oracle Health/Cerner, etc.)
2. Oncology-specific data coverage (stage, biomarkers, mutations, prior lines of therapy)
3. HIPAA/security model and data governance
4. Whether it supports pre-screening only or full recruitment workflow
5. Real-world metrics: screen-to-enrollment conversion, coordinator time saved, and false-positive match rates

If you are a cancer center, CRO, or pharma sponsor, the shortlist would differ because the optimal tool depends heavily on whether you need internal EMR mining, multi-site feasibility, or actual patient outreach.

Improving oncology patient recruitment via Electronic Medical Record (EMR/EHR) data requires specialized software that can handle complex, unstructured oncology data (such as biomarker status, genomic sequencing, staging, and previous lines of therapy) and map them against strict trial inclusion/exclusion criteria.

The leading software solutions designed to analyze EMR data for oncology clinical trial matching and recruitment include:

1. Tempus AI (TIME Program & Patient Query)
   • Overview: Tempus has built a massive platform explicitly engineered for precision oncology. Their software utilizes secure EMR integrations and AI-powered applications (such as their TApp/Patient Query tools) to mine structured and unstructured clinical/genomic data.
   • Best For: Connecting provider networks to a broad portfolio of advanced and Phase I oncology trials by automatically matching genomic profiles from medical records.
2. TriNetX
   • Overview: TriNetX provides a global federated health research network and analytics platform. It allows researchers and sponsors to query real-world EMR data across millions of patient records to assess protocol feasibility, pinpoint exact patient volumes, and identify specific care sites where eligible oncology cohorts are actively receiving treatment.
   • Best For: Protocol optimization, feasibility analysis, and identifying candidate healthcare organizations/sites based on live patient distributions.
3. Massive Bio (Synergy AI)
   • Overview: Massive Bio uses advanced AI, computer vision, and natural language processing (NLP) to extract structured clinical data from unstructured EMR notes. It maps this data against a vast, parameterized library of actively recruiting interventional cancer trials and pairs the software with human concierge support for sites.
   • Best For: Automated pre-screening and abstracting complex oncological criteria from deep medical record text without requiring heavy manual chart reviews.
4. Trialbee & Clinerion Integration
   • Overview: Clinerion specializes in real-time, real-patient EMR/EHR data informatics, which pairs with Trialbee’s omnichannel patient-matching and tracking platform (Honey ). Together, they turn static hospital data into active, real-time recruitment pipelines while maintaining transparency for clinical research coordinators.
   • Best For: Streamlining the pathway from EMR data identification down to digital pre-qualification and tracking referral performance.

To help narrow down which tool fits your infrastructure best, tell me:

• Which EMR vendor are you currently using (e.g., Epic, Cerner/Oracle Health, Athenahealth)?
• Are you looking for a tool to pull data across a large hospital network or manage recruitment for a single oncology site?

For oncology trials, the software category you’re looking for is usually called AI-powered clinical trial matching, EMR/EHR patient identification, or protocol feasibility and recruitment analytics. These platforms ingest structured EMR data (diagnoses, labs, medications, genomics) and often use NLP/AI to extract eligibility signals from unstructured notes, pathology reports, radiology reports, and clinician documentation.

Some leading options to evaluate:

What to look for in an oncology recruitment platform

• NLP over clinical notes Many oncology eligibility criteria are buried in free text (e.g., ECOG status, prior therapies, metastatic sites, biomarker results), so simple database queries often miss candidates.
• Pathology and genomics support Modern oncology trials frequently require biomarkers such as mutations, expression markers, or sequencing results.
• EHR integration Look for standards-based integrations (FHIR/SMART on FHIR where possible) with systems such as Epic, Oracle Health (Cerner), and other major EHRs.
• Evidence-backed matching The best systems show why a patient matched (lab value, pathology finding, medication history, note excerpt), allowing coordinators to verify quickly.
• Workflow support Candidate identification alone is not enough; look for referral routing, coordinator task management, prescreen tracking, and audit trails.

A practical evaluation approach

For an oncology program, I would typically compare vendors using a pilot:

1. Select 2–3 active trials with difficult enrollment criteria.
2. Run retrospective matching against your EMR population.
3. Measure: - eligible patients found vs. manual review

• false-positive rate
• time saved per coordinator
• conversion from identified → screened → enrolled

4. Confirm HIPAA/privacy controls, data governance, and integration effort.

If you are a cancer center, pharma sponsor, or CRO, the best fit can differ substantially (site-level EMR mining vs. multi-site recruitment network vs. global trial feasibility).

Top software platforms for analyzing EMR/EHR data to recruit oncology trial candidates include Deep 6 AI, Paradigm (incorporating Deep Lens), and TrialX, alongside enterprise clinical suites like Medidata and IQVIA .

To accelerate patient recruitment, specialized clinical trial matching software integrates directly with electronic medical records (EMRs) to parse both structured data (labs, demographics, ICD codes) and unstructured data (pathology reports, clinical notes) against complex oncology trial criteria.

Leading EMR-Integrated Oncology Recruitment Software

• Deep 6 AI : Uses advanced natural language processing (NLP) to read unstructured physician notes, pathology reports, and clinical narratives within EMRs, enabling teams to match complex oncology criteria beyond basic billing codes.
• Paradigm Health (incorporating Deep Lens): Operates a network and data orchestration platform specifically designed to embed clinical trial matching directly into community oncology and health system workflows.
• TrialX : Offers clinical trial matching tools like iConnect , which integrate with EHR systems to parse patient summaries and match them against trial eligibility criteria.
• Enterprise CTMS Solutions (Medidata, Veeva, IQVIA) : Large-scale clinical trial management and data platforms featuring integrated patient recruitment, feasibility analytics, and real-world data networks.
• Antidote : Provides self-service health-data platforms and structured matching engines that turn complex trial criteria into tools compatible with modern clinical workflows.

Key Capabilities to Evaluate

• NLP & Unstructured Data Parsing : The software must interpret narrative doctor notes and genomic/pathology text files, not just structured billing codes.
• Complex Criteria Matching : Ability to simultaneously model multi-layered inclusion/exclusion requirements like specific precision oncology biomarkers and prior lines of therapy.
• EHR Interoperability : Seamless integration with your specific EMR environment (Epic, Cerner/Oracle Health) with robust HIPAA compliance and security standards.
• Workflow Automation : Automated alerts for care teams and coordinators when an eligible patient walks through the door or has a routine lab processed.

To narrow down the best platform, tell me:

• What EMR system (e.g., Epic, Oracle Health) are you currently using?
• Are you looking for a site-level tool for a single health system or an enterprise-wide solution for a sponsor/network?

Improving patient recruitment in oncology trials via EMR/EHR data analysis relies on software that combines structured data (like ICD-10 diagnosis codes and lab results) with unstructured data (like physician clinical notes and pathology reports) using Natural Language Processing (NLP) or AI.

Leading software solutions specializing in EMR-driven oncology trial matching and patient recruitment include:

• Tempus (TIME Program): Deeply integrated into oncology networks, Tempus uses AI-enabled tools (like the TApp screening application) that connect directly with EMR systems to match patient genomic and clinical profiles against a broad portfolio of active cancer trials.
• Deep Lens (VIPER): Specifically built for oncology, Deep Lens integrates directly with EMRs across community and network oncology practices. Its VIPER platform continuously ingests structured and unstructured patient data to surface eligible candidates in real-time as patients are diagnosed or as their treatment progresses.
• TriNetX (TriNetX Live): A global health research network that connects directly to EMR data to query both structured data and unstructured clinical notes. It allows clinical teams and sponsors to run feasibility assessments and match patient cohorts against complex trial criteria seamlessly.
• Verana Health: Utilizes advanced AI technology to securely parse structured and unstructured EHR data to match patient cohorts to complex protocol criteria with high precision, assisting with predictive modeling for site selection.
• BEKhealth: Uses a proprietary medical ontology and AI to analyze deep EMR data (both text notes and coded data) mapped against trial protocols, significantly shortening manual chart-review cycles.
• Haystack Health (Haystack Enroll): Focuses heavily on applying NLP to unstructured medical records, automating the initial chart review and presenting precision-matched candidate lists for study teams to validate.

If you'd like to narrow this down, let me know:

• Are you looking for a tool for a single health system/cancer center or a multi-site sponsor/CRO network?
• Which EMR vendor (e.g., Epic, Cerner/Oracle Health) do your sites primarily use?

I can provide a more tailored recommendation and implementation overview.

Yes. For oncology trial recruitment, I’d focus on platforms that can search both structured EMR/EHR fields and unstructured clinical text—because key eligibility information often lives in notes, pathology, radiology, biomarker reports, and treatment history.

Strong options

• deep6.ai — Probably the most direct fit if your goal is “search our EMR and surface patients who may qualify.” It uses AI/NLP across structured data plus physician notes, pathology, radiology, labs, and other clinical information. Rutgers, for example, uses it to generate potential participant lists after IRB approval.
• tempus.com — Particularly attractive for oncology. Its platform performs AI-based prescreening against trial criteria and can process structured and unstructured clinical notes. Tempus also combines the software with an oncology-focused trial/site network.
• trinetx.com — Best if you need more than patient matching: cohort feasibility, protocol optimization, site selection, and cross-institutional population analysis. Its newer Clinical Notes capability makes unstructured clinical information queryable alongside structured EHR data.

How I'd choose

One important point: “AI match” shouldn't equal “eligible.” The best systems should give your research staff the evidence behind the match and allow clinical review. This matters especially for oncology criteria such as stage, histology, prior lines of therapy, progression dates, ECOG status, biomarker results, and time-dependent lab criteria. Tempus's recent oncology work explicitly notes that much of the information needed for matching resides in unstructured documentation.

For a vendor evaluation, I'd give each platform 2–3 of your actual oncology protocols and ask them to demonstrate the complete workflow from EMR → AI prescreen → evidence for each criterion → coordinator review → investigator confirmation. That will tell you much more than a generic product demo.

If you tell me whether you're a hospital/academic cancer center, community oncology practice, CRO, or pharma sponsor, I can narrow this to the best 2–3 choices and compare EHR integration, oncology/biomarker capabilities, implementation effort, workflow, and pricing model.

Improving patient recruitment in oncology trials requires software that can ingest and analyze both structured EMR data (labs, demographics, medications) and unstructured clinical data (physician notes, pathology reports, genomic/molecular sequencing results).

Several leading platforms integrate with electronic health records (EHRs/EMRs) to automate and accelerate this process:

• Tempus AI (TIME Program / TApp): Uses AI and Natural Language Processing (NLP) to ingest EMR and Next-Generation Sequencing (NGS) molecular data. Its proprietary matching software (TApp) executes daily algorithmic matching against complex oncology trial portfolios, helping pinpoint high-fidelity candidates based on exact genetic mutations.
• Flatiron Health: Deeply embedded in oncology practices, Flatiron’s EHR-derived platforms feature built-in clinical trial eligibility screening. It matches patients dynamically using structured profiles and real-world evidence data, bridging everyday clinical care with active research protocols.
• TriNetX: A globally federated real-world data network that connects healthcare organizations and clinical sites. TriNetX LIVE allows researchers to perform feasibility queries, analyze live patient populations against strict protocol criteria, and identify matching oncology cohorts securely across EHR and genomic datasets.
• Paradigm Health: Deploys an AI-driven, EHR-integrated platform that continuously evaluates structured and unstructured clinical and genomic data against trial criteria. It surfaces prospective candidates directly within the clinical workflow and tracks them through the screening pipeline.

If you'd like to narrow this down, let me know:

• Are you looking for a tool for a single community practice, a large academic cancer center, or as a sponsor/CRO?
• Do you need native genomic/molecular matching capabilities?
• Which EHR system (e.g., Epic, Cerner, Flatiron) are your sites currently running?

Yes. For oncology trial recruitment from EMR/EHR data, the strongest options to evaluate are:

• tempus.com — particularly strong for oncology. It uses AI/NLP to identify potential trial candidates from clinical data and supports biomarker-driven matching, prescreening, and recruitment workflows. Tempus reports a network covering 5M+ cancer patients and 1,000+ clinical locations.
• trinetx.com — excellent if you want cohort discovery, feasibility, site selection, and patient identification in one platform. Its no-code environment lets research teams query large real-world datasets against eligibility criteria.
• Deep 6 AI — worth considering when your biggest problem is extracting eligibility signals from unstructured EMR content, such as pathology reports, physician notes, and operative notes, rather than just diagnosis/procedure codes. Its approach combines structured and unstructured EHR data with NLP.
• Epic-integrated matching tools / XpertScreen-type systems — attractive when you want matching to occur inside the clinician's existing EHR workflow, rather than asking coordinators to work in a separate application. Published work on XpertScreen describes ML/NLP extraction of complex eligibility criteria and EMR-integrated searching.

What I'd choose

If you're a cancer center trying to increase enrollment at your own sites, I'd shortlist Tempus and Deep 6 AI first. They are particularly relevant when eligibility depends on things like stage, prior lines of therapy, pathology, biomarkers, and information buried in free-text notes.

If you're a large health system/research organization that also needs protocol feasibility, cohort analytics, and site identification, TriNetX is probably the broader platform.

One important caveat: these systems should generally be treated as prescreening/decision-support tools, not as the final determination of eligibility. Current NCI work emphasizes that reliable matching requires both standardized patient data and computable eligibility criteria, with human review still important.

If you tell me whether you're a hospital/cancer center, CRO, or pharma sponsor, I can give you a more specific top-5 comparison covering EMR integration, oncology depth, NLP capabilities, implementation effort, and likely cost model.

To improve patient recruitment in oncology trials, specialized clinical trial matching and real-world data (RWD) platforms integrate directly with Electronic Medical Records (EMRs/EHRs). Oncology recruitment is uniquely complex because eligibility often hinges on deep, unstructured details buried in pathology, genomic/molecular sequencing reports, and physician narrative notes.

Leading software solutions leverage Artificial Intelligence (AI) and Natural Language Processing (NLP) to parse both structured and unstructured EMR data for trial matching:

• Deep 6 AI (acquired by Tempus) : Connects directly with hospital EMR systems to parse structured data alongside messy, unstructured clinical text like pathology, genomic profiles, and physician notes. It uses advanced NLP and context-aware logic to build precise patient cohorts and match them against complex oncology trial criteria.
• Tempus TIME : A data-integrated oncology trial network and matching platform built specifically around cancer care. It connects real-time clinical and molecular data to accelerate patient identification and streamline study onboarding across cancer centers.
• TriNetX : A globally recognized federated health research network that links EMRs to evaluate protocol feasibility, run feasibility queries, and identify patient populations for oncology and other complex therapeutic areas using real-world evidence (RWE).
• Paradigm Health : Deploys an AI-driven, EHR-integrated platform that specifically targets molecular and genomic testing results within clinical workflows. It surfaces eligible oncology candidates with a clear clinical rationale and pairs the software with dedicated clinical coordinators to push recruitment forward.

To help narrow down which platform fits your infrastructure best, let me know:

• Which EMR system (e.g., Epic, Cerner/Oracle Health) are you currently running?
• Are you looking for a tool focused strictly on internal site screening , or a broader federated network that also helps with trial feasibility and sponsor visibility?

Yes. For oncology trial recruitment from EMR/EHR data, the strongest options to evaluate are:

My shortlist

If your primary objective is “search our EMR and continuously surface oncology patients who may qualify for our trials,” I'd start with Tempus/Deep 6 and TriNetX.

The important distinction is that you don't want a system that only searches diagnosis codes. Oncology eligibility often depends on information buried in pathology, staging, prior therapies, biomarkers, performance status, laboratory results, and free-text notes. Deep 6/Tempus specifically emphasizes structured and unstructured EMR data, while recent oncology research supports hybrid rules + NLP approaches for this problem.

One encouraging recent example: Tempus reported that its Patient Query tool screened out about 72% of initially ineligible patients across eight trials, with 94.39% overall query accuracy in the evaluated queries. Those are vendor-reported results, so I'd validate them against your own oncology population before selecting a platform.

What I'd require in an RFP

• Structured + unstructured EMR search — not just ICD/CPT codes.
• Protocol-to-query conversion for complex inclusion/exclusion criteria.
• Explainable matches: show why the patient matched and which criterion still requires human verification.
• Real-time/continuous monitoring, rather than a one-time cohort export.
• Biomarker/genomic matching, particularly for precision-oncology trials.
• Epic/EHR integration and FHIR/API capabilities.
• Human clinical-review workflow for final prescreening.
• HIPAA/IRB/privacy controls and clear rules around identifiable patient data.
• Metrics such as eligible patients surfaced → chart reviews → approached → consented → enrolled, rather than simply “number of matches.”

I'd also be cautious about treating an AI match as an eligibility determination. Current work in the field emphasizes human validation and traceability because eligibility criteria and clinical data are often ambiguous.

If you tell me whether you're a pharma sponsor, CRO, academic cancer center, or community oncology practice, I can narrow this to the 3–5 best platforms and compare capabilities, integrations, likely implementation effort, and pricing model.